2021 annual financial data
AnaptysBio 2021 Operating margin
Direct answer
Operating margin was -89.93%.
Operating income was -56,814,000 USD and net income was -57,796,000 USD.
Operating cash flow was -45,920,000 USD.
Get free AnaptysBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 63,175,000 USD
- Operating income
- -56,814,000 USD
- Net income
- -57,796,000 USD
- Operating cash flow
- -45,920,000 USD